Investigating the Plasticity of Human Predictive Coding Through Neuromodulation

NCT06374433 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2024-06-14

No results posted yet for this study

Summary

The hypothesis of the study is to investigate how different trm (tES) methods (transcranial Alternating Current Stimulation, tACS, and transcranial Random Noise Stimulation, tRNS) applied at different stimulation frequencies and networks can modulate the predictive mechanisms in human perception and cognition. This is an interventional, monocentric, cross-sectional randomized, single-blinded study on healthy adult volunteers, recruited through online advertisements, flyers and oral transmission. Volunteers will be recruited from the general population of young adults.

Conditions

  • Human Brain and Cognition

Interventions

PROCEDURE

Occipital tACS at IAF-2Hz

tACS applied to occipital areas at 2 Hz below the individual alpha frequency (IAF)

PROCEDURE

Occipital tACS at IAF+2Hz

tACS applied to occipital areas at 2 Hz above the individual alpha frequency (IAF)

PROCEDURE

Frontal tACS at 4-7 Hz

tACS applied to frontal areas at 4-7 Hz

PROCEDURE

Occipital tRNS

tRNS applied to occipital brain regions

PROCEDURE

Frontal tRNS

tRNS applied to frontal brain regions

PROCEDURE

Sham/placebo tACS

tACS is activated only for 30 seconds and then turned off, thus resulting ineffective

PROCEDURE

Sham/placebo tRNS

tRNS is activated only for 30 seconds and then turned off, thus resulting ineffective

Sponsors & Collaborators

  • Alessia Santoni

    collaborator UNKNOWN
  • Sara Stottmeier

    collaborator UNKNOWN
  • Klara Hemmerich

    collaborator UNKNOWN
  • Giuseppe Di Dona

    collaborator UNKNOWN
  • Luigi Ferini-Strambi

    collaborator UNKNOWN
  • Università Vita-Salute San Raffaele

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-13
Primary Completion
2026-04-30
Completion
2026-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06374433 on ClinicalTrials.gov